Signature Healthcare At Home | |
834 South Front Street, Central Point, Oregon 97502 | |
(541) 664-7400 | |
Name | Signature Healthcare At Home |
---|---|
Location | 834 South Front Street, Central Point, Oregon |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 387142 |
Ownership Type | Proprietary |
Service Area Zip Codes | 97484, 97501, 97502, 97503, 97504, 97520, 97523, 97524, 97525, 97526, 97527, 97528, 97530, 97531, 97532, 97534, 97535, 97536, 97537, 97539, 97540, 97541, 97544, 97601 |
NPI Number | 1780772996 |
Organization Name | AVAMERE HOME HEALTH CARE, LLC |
Doing Business As | SIGNATURE HOME HEALTH-WATERFORD |
Address | 834 S Front St, Central Point, OR 97502 |
Phone Number | 541-664-7400 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
Quality Rating: |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 89.4 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 98.3 | 98.6 |
How often the home health team checked patients’ risk of falling | 99.6 | 99.6 |
How often the home health team checked patients for depression | 98.7 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 66.8 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 72.1 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 94.6 | 96.4 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 72.4 | 79.6 |
How often patients got better at getting in and out of bed | 77.3 | 81.1 |
How often patients got better at bathing | 78.2 | 82.3 |
How often patients’ breathing improved | 76.4 | 82.8 |
How often patients’ wounds improved or healed after an operation | 96 | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 62.3 | 75 |
How often home health patients had to be admitted to the hospital | 16.5 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 19.1 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 97.3 | 94 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
The patient survey data of Signature Healthcare At Home is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 84 | 88 |
Percent of patients who reported that their home health team communicated well with them | 79 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 81 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 77 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 76 | 78 |
News Archive
Boehringer Ingelheim Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration has approved Viramune XR extended-release tablets, a one-pill, once-daily formulation of nevirapine for use in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults.
California's state Medicaid chief is promising changes to dental care for kids, and North Carolina rolls out a medical home model for pregnant women.
CIC microGUNE, the Co-operative Research Centre into Microtechnologies, is coordinating the microSCALE project which seeks to generate innovative solutions based on microtechnologies to tackle the problems of the mobility industry and life sciences, among others.
Women who experience gender-based violence such as rape, sexual assault, intimate partner violence and stalking have a higher lifetime prevalence of mental health disorders, dysfunction and disability, new Australian research shows.
› Verified 9 days ago
Signature Healthcare At Home Location: 834 South Front Street, Central Point, Oregon 97502 Ratings: Phone: (541) 664-7400 |